IBRX: ImmunityBio Inc - Common Stock

2.56 USD 0.02 (0.78%)

Secteur: Soins de Santé Base: US Dollar Devise de profit: US Dollar

Le taux de change de IBRX a changé de -0.78% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 2.54 et à un maximum de 2.67.

Suivez la dynamique ImmunityBio Inc - Common Stock. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.

Graphique en Plein Ecran

IBRX Nouvelles

Investing 16:34 Trump administration prepares emergency declaration for Brazil tariffs - Bloomberg
Benzinga 06:36 LA Times Going Public? Patrick Soon-Shiong Plans Green Bay-Style Ownership To 'Democratize' 143-Year-Old Paper - ImmunityBio (NASDAQ:IBRX)
Investing 05:30 Los Angeles Times to go public, owner Soon-Shiong says
Seeking Alpha 14:45 ImmunityBio Stock: Still Flashing Signs Life After Another ANKTIVA Approval (NASDAQ:IBRX)
Seeking Alpha 10:51 ImmunityBio: High Stakes On ANKTIVA's Growth Amidst FDA Friction And Financial Pressures
Seeking Alpha 13:09 ImmunityBio: Lymphopenia Opportunity Could Provoke Short Squeeze (NASDAQ:IBRX)
Investing 18:05 Alibaba, Tesla Lead Market Cap Stock Movers on Wednesday
Investing 11:37 H.C. Wainwright maintains buy rating on ImmunityBio stock after FDA milestones
Investing 13:04 ASCO Report of Pioneering Treatment of Lymphopenia with Significant Overall Survival Benefit in Advanced Pancreatic Cancer
Investing 14:31 Nvidia, Veeva Surge Among Thursday’s Market Cap Stock Movers
Investing 12:32 ImmunityBio, Saudi Arabia’s Ministry of Investment, KFSHRC, and KAIMRC Sign Strategic Memorandum of Understanding to Launch Cancer BioShield™ Platform in the Middle East
Investing 14:31 Amer Sports, Viking Holdings lead Tuesday’s market cap stock movers
Investing 11:30 Piper Sandler raises ImmunityBio stock rating, target to $5
Benzinga 17:11 Foot Locker And Archer Aviation Are Among Top 8 Mid-Cap Gainers Last Week (May 12-May 16): Are The Others In Your Portfolio? - Archer Aviation (NYSE:ACHR), Foot Locker (NYSE:FL)
Benzinga 13:21 ImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug - ImmunityBio (NASDAQ:IBRX)
Benzinga 12:18 Netflix, CNA Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Guardant Health (NASDAQ:GH), CNA Financial (NYSE:CNA)
Investing 11:59 ImmunityBio stock sinks after FDA issues RTF letter
Seeking Alpha 21:54 ImmunityBio: Taking Care Of Business (NASDAQ:IBRX)
Benzinga 14:15 Concentrix Posts Better-Than-Expected Earnings, Joins Soleno Therapeutics, Petco Health and Wellness, MillerKnoll And Other Big Stocks Moving Higher On Thursday - Avis Budget Gr (NASDAQ:CAR), Concentrix (NASDAQ:CNXC)
Seeking Alpha 06:47 ImmunityBio: BCG Shortage And Tariff Risks May Stifle Anktiva’s Commercial Momentum (IBRX)
Benzinga 18:09 ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug - ImmunityBio (NASDAQ:IBRX)
Benzinga 14:33 This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - ImmunityBio (NASDAQ:IBRX), Aduro Clean Technologies (NASDAQ:ADUR)
Investing 21:32 ImmunityBio stock rises on Q4 earnings beat, revenue growth
Benzinga 17:18 Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday? - SPDR S&P 500 (ARCA:SPY)

Range quotidien

2.54 2.67

Range Annuel

1.83 7.49

Clôture Précédente: 2.54
Ouverture: 2.58

Bid: 2.56
Ask: 2.86

Plus Bas: 2.54
Plus Haut: 2.67

Volume: 4.313 K

Changement quotidien: -0.78%
Changement Mensuel: -1.54%

Changement à 6 Mois: -21.71%
Changement Annuel: -50.29%

31 juillet, jeudi